Brazil introduces new regs for generics

9 January 2001

By April 23, 2001, generic drugs sold in Brazil must be in line with newregulations from Anvisa, the country's pharmaceutical regulatory agency. The new laws on labeling and packaging are meant to distinguish generics from branded products and improve safety, notes an article in Chemical Market Reporter.

Generic drug labels may not carry the name of proprietary drugs to which they are similar, and generic contents must be listed beneath the generic brand name in a type font 50% smaller than the size of type used for the product's name. The use of safety seals or packaging is also mandated.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight